Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents)

Editorial [Hot Topic: Tyrosine Kinase Inhibitors in Cancer Therapy (Guest Editor: S. Eckhardt)]
pp. 461-461(1)
Author: Eckhardt, S.

Antiangiogenic Drugs and Tyrosine Kinases
pp. 462-469(8)
Authors: Timar, Jozsef; Dome, Balazs

Novel Molecular-Targeted Therapeutics for the Treatment of Cancer
pp. 470-480(11)
Authors: Yasui, Hiroshi; Imai, Kohzoh

Inhibition of Receptor Tyrosine Kinases in Combination with Chemotherapy for the Treatment of Breast Cancer
pp. 481-487(7)
Authors: Moulder, S. L.; Craft, B. S.; Hortobagyi, G. N.

HER-2 Positive Breast Cancer: What Else Beyond Trastuzumab-Based Therapy?
pp. 488-496(9)
Authors: Widakowich, Christian; Dinh, Phuong; Azambuja, Evandro d.; Awada, Ahmad; Piccart-Gebhart, Martine

New Trends in Molecular Imaging of Tumor Angiogenesis
pp. 497-522(26)
Authors: Berthelot, Thomas; Lasne, Marie-Claire; Deleris, Gerard

Monoclonal Antibodies in Clinical Oncology
pp. 523-532(10)
Authors: Dalle, S.; Thieblemont, C.; Thomas, L.; Dumontet, C.

Targeting Inhibitor of Apoptosis Proteins (IAPs) for Cancer Therapy
pp. 533-539(7)
Author: Fulda, Simone

Bile Acids and Derivatives, Their Nuclear Receptors FXR, PXR and Ligands: Role in Health and Disease and Their Therapeutic Potential
pp. 540-563(24)
Authors: Zimber, Amazia; Gespach, Christian

p53 Targeting Can Enhance Cancer Therapy via Radiation, Heat and Anti-Cancer Agents
pp. 564-570(7)
Authors: Ohnishi, Takeo; Takahashi, Akihisa; Mori, Eiichiro; Ohnishi, Ken

Hyperthermia Associated Osteonecrosis in Young Patients with Pelvic Malignancies
pp. 571-575(5)
Authors: Jager, Marcus; Balzer, Stefan; Wessalowski, Rudiger; Schaper, J.; Gobel, Ulrich; Li, Xinning; Krauspe, Rudiger